# A Clinical Trial of Fluvoxamine for Melancholia

> **NCT04160377** · PHASE2 · UNKNOWN · sponsor: **Lingjiang Li** · enrollment: 150 (estimated)

## Conditions studied

- Depressive Disorder
- Endogenous Depression
- Melancholia

## Interventions

- **DRUG:** Fluvoxamine

## Key facts

- **NCT ID:** NCT04160377
- **Lead sponsor:** Lingjiang Li
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04160377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04160377, "A Clinical Trial of Fluvoxamine for Melancholia". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT04160377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*